KANTO DENKA KOGYO CO.,LTD. FY2027 Q1 Earnings Report

Quick View

Executive Summary

Revenue and profit both increased substantially, resulting in higher revenue and higher earnings as improvements in pricing and product mix dramatically enhanced profitability. Revenue was ¥19.77B (+30.6% year on year), Operating Income was ¥3.98B (+410.7%), Ordinary Income was ¥4.57B (+515.5%), and Net Income was ¥3.25B (+488.9%). The primary factor was margin expansion driven by improved demand and pricing in the Precision Chemicals Business, with the Operating Income margin surging from approximately 3.8% in the previous year to 20.1%.

Factors Affecting Financial Results

【Revenue】Revenue was ¥19.77B, up +30.6% year on year. The Precision Chemicals Business led growth, generating ¥16.52B (+38.3%) and accounting for 80.8% of total revenue, while the Equipment Business declined to ¥0.82B (-21.7%). The Basic Chemicals, Iron-Based Products, and Trading businesses posted only modest revenue increases.

【Profit and Loss】Operating Income was ¥3.98B (+410.7%), the gross margin expanded to 34.4%, and the SG&A ratio declined to 14.3%, resulting in operating leverage. Ordinary Income was ¥4.57B (+515.5%), supported by non-operating income including foreign exchange gains of ¥0.44B and dividend income of ¥0.24B. Extraordinary losses were a minor ¥0.01B. Net Income was ¥3.25B (+488.9%). The results reflect both revenue and earnings growth, with improved profitability attributable to both changes in product mix and cost efficiencies.

Segment Analysis

The Precision Chemicals Business generated revenue of ¥16.52B (+38.3%), Operating Income of ¥3.75B (+550.3%), and a profit margin of 22.7%, producing nearly all of the Company-wide profit. The Iron-Based Products Business remained solid, with revenue of ¥0.55B (+3.2%) and a profit margin of 18.9%. Basic Chemicals generated revenue of ¥2.08B (+6.1%), but its profit margin was low at 3.4%. The Trading Business recorded Operating Income of ¥0.04B, down -20.4% year on year. The Equipment Business generated revenue of ¥0.82B (-21.7%) and posted an Operating Loss of ¥0.01B, falling into the red, highlighting the pronounced polarization in profitability among segments. The high dependence on Precision Chemicals, which accounts for 80.8% of revenue, warrants attention as a future source of volatility.

Key Financial Indicators

【Profitability】The Operating Income margin was 20.1% and the Net Income margin was 16.4%, representing substantial improvements from the previous year’s Operating Income margin of 5.1% and Net Income margin of 3.6%. The gross margin also expanded to 34.4%, supported by pricing and product-mix factors as well as cost controls.【Cash Flow Quality】Inventories increased to ¥9.20B (¥6.59B in the previous year), while accounts receivable and notes receivable increased to ¥19.67B (¥17.64B in the previous year), indicating that working capital expansion is outpacing earnings growth.【Investment Efficiency】ROE was 4.2%, with the low total asset turnover ratio structurally constraining capital efficiency.【Financial Soundness】The Equity Ratio remained high at 55.4% (55.1% in the previous year). The Company held cash and deposits of ¥18.65B against long-term borrowings of ¥25.44B, indicating a sound financial base.

Cash Flow Analysis

As the cash flow statement is not disclosed in this report, funding trends are analyzed based on changes in the balance sheet. Inventories increased +39.6% year on year, while short-term borrowings increased +182.2%; both rose substantially, indicating that heightened working capital requirements associated with business expansion are being reflected in financing activities. Meanwhile, cash and deposits stood at ¥18.65B, slightly below ¥20.22B in the previous year, suggesting that part of the inventory buildup and funding requirements may have been absorbed through a reduction in cash on hand and short-term borrowings. The Equity Ratio remained at 55.4%, and long-term borrowings declined from the previous year, indicating that the overall financing structure continues to reflect a conservative stance.

Quality of Earnings

Recurring earnings are centered on Operating Income, while extraordinary losses of ¥0.01B were minor relative to Net Income, indicating limited effects from temporary factors. Of non-operating income of ¥0.75B, foreign exchange gains accounted for ¥0.44B, equivalent to approximately 11% of Operating Income and approximately 9.6% of Ordinary Income, making this a highly volatile item. Dividend income of ¥0.24B can be regarded as a stable source of earnings. The difference between Ordinary Income and Net Income is primarily attributable to income taxes of ¥1.32B. The effective tax rate was approximately 28.9% of pre-tax income of ¥4.56B, a standard level. Increases in inventories and accounts receivable suggest a possible timing mismatch in cash conversion relative to earnings growth. From an accrual perspective, monitoring future inventory sell-through and collection trends would be useful.

Earnings Forecast and Guidance

Progress against the Full-Year forecast was 20.8% for revenue (¥19.77B against the forecast of ¥95.00B), 35.2% for Operating Income (¥3.98B against the forecast of ¥11.30B), and 42.8% for Net Income (¥3.25B against the forecast of ¥0.76B). While revenue progress was slightly below a simple one-quarter benchmark of 25%, profit progress was substantially ahead, indicating that margin improvement in Q1 has pulled forward earnings progress. The earnings forecast was revised during the quarter, making the accuracy of the Full-Year outlook a key focus going forward. The dividend forecast was unchanged at 36 yen.

Shareholder Returns

The Full-Year dividend forecast is 36 yen per share, an increase from the previous year’s dividend of 9 yen (actual result before the aggregation of the interim and year-end dividends). Based on forecast EPS of 132.51 yen, the Payout Ratio is approximately 27.2%, remaining conservative relative to the earnings level. No disclosure regarding share buybacks was made, and the shareholder return policy is centered on dividends. As earnings progress is ahead of schedule in the current fiscal year, the Full-Year Payout Ratio may change after the financial results are finalized.

Risk Factors

1. Business concentration risk: The Precision Chemicals Business accounts for 80.8% of revenue and nearly all Operating Income, so fluctuations in demand and pricing in this business could have a significant impact on overall results.

2. Working capital expansion risk: Inventories increased +39.6% year on year, while accounts receivable and notes receivable increased +11.5%, creating the possibility that cash collection and inventory sell-through may lag earnings growth.

3. Foreign exchange sensitivity: Foreign exchange gains of ¥0.44B included in non-operating income account for approximately 9.6% of Ordinary Income. If foreign exchange trends reverse, Ordinary Income could be materially affected.

Industry Benchmark (For Reference; Company Analysis)

Industry Benchmark (manufacturing)

Profitability and Returns

Profitability significantly exceeds the industry median and is positioned in the upper range.

Growth and Capital Efficiency

The revenue growth rate is also outstanding within the industry, placing the Company in the upper tier in terms of growth.

Source: Company aggregation

Key Points from the Financial Results

1. Improvements in pricing and product mix and greater cost efficiency in the Precision Chemicals Business expanded the Operating Income margin to 20.1%, substantially above the industry median. Whether this improvement is structural or attributable to temporary market conditions needs to be confirmed through trends over multiple future quarters.

2. Profit progress against the Full-Year forecast is ahead of schedule, at 35.2% for Operating Income and 42.8% for Net Income. It is useful to assess this performance while considering the contribution of foreign exchange gains to Ordinary Income.

3. The pace of increase in inventories and accounts receivable is exceeding revenue growth. Trends in working capital will be a key factor affecting future cash generation, making developments from the next quarter onward an area of focus.

Theoretical Share Price (Reference Value)

Sensitivity: 1,335 yen–1,414 yen at ±1% for the cost of equity, and 1,372 yen–1,375 yen at ±0.1 for ω.

Notes:

• As Net Income progress against the Full-Year forecast (43%) exceeds the standard benchmark (25%), forecast EPS has been adjusted upward within a maximum range of +10% (because companies with progress ahead of schedule tend to exceed forecasts. For businesses with strong seasonality, the adjustment may be excessive).
• Net assets at the end of the quarter are used (there is a timing mismatch with the Full-Year forecast).

(Calculation model: Residual Income Model (Ohlson-type, explicit five-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated solely from publicly disclosed data; this does not constitute a forecast of the market share price or a recommendation of any specific investment action, nor does it predict or guarantee future share prices.)

---

This report is an earnings analysis document automatically generated by AI through analysis of XBRL earnings release data. It does not recommend investment in any specific security. The industry benchmarks are reference information aggregated by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own discretion and responsibility, after consulting with a professional as necessary.

---End of Report---